DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

H.C. Wainwright Reiterates Neutral on Syros Pharmaceuticals, Lowers Price Target to $8

H.C. Wainwright analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Neutral and lowers the price target from $10 to $8.

Benzinga · 03/06/2020 13:09

H.C. Wainwright analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Neutral and lowers the price target from $10 to $8.